Skip to main content
. 2018 Jan 11;13(1):e0191195. doi: 10.1371/journal.pone.0191195

Table 1. Clinicopathological parameters of subjects analyzed by miRNA microarray.

Number Case ID Tumor type Age (years) UICC Stage ER status PR status HER2/neu
1 1 (T) IDC 33.3 2A negative negative positive
2 2 (N) - 31.8 - - - -
3 2 (T) IDC 31.8 2A positive positive negative
4 3 (N) - 29.5 - - - -
5 3 (T) DCIS 29.5 0 positive positive negative
6 4 (T) IDC 32.6 1 negative negative positive
7 5 (T) DCIS 28.6 0 positive positive negative
8 6 (N) - 35.1 - - - -
9 8 (T) IDC 33.7 2A positive positive negative
10 P (N) - - - - - -

ID, identification; N, normal breast tissue; T, breast tumor; DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; P, pooled normal sample; ER, estrogen receptor; PR, progesterone receptor; HER2/neu, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 receptors; UICC, stage of breast tumor according to the international union for cancer staging criteria.